Metallothionein and Superoxide Dismutase—Antioxidative Protein Status in Fullerene-Doxorubicin Delivery to MCF-7 Human Breast Cancer Cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metallothionein and Superoxide Dismutase—Antioxidative Protein Status in Fullerene-Doxorubicin Delivery to MCF-7 Human Breast Cancer Cells
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 10, Pages 3253
Publisher
MDPI AG
Online
2018-10-23
DOI
10.3390/ijms19103253
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fullerene as a doxorubicin nanotransporter for targeted breast cancer therapy: Capillary electrophoresis analysis
- (2018) Marta Kepinska et al. ELECTROPHORESIS
- An insight into the complex roles of metallothioneins in malignant diseases with emphasis on (sub)isoforms/isoforms and epigenetics phenomena
- (2018) Sona Krizkova et al. PHARMACOLOGY & THERAPEUTICS
- Carbon Nanomaterials for Targeted Cancer Therapy Drugs: A Critical Review
- (2018) Bozena Hosnedlova et al. CHEMICAL RECORD
- The role of metallothionein in oncogenesis and cancer treatment
- (2017) Anna Bizoń et al. Postepy Higieny I Medycyny Doswiadczalnej
- Zinc-Modified Nanotransporter of Doxorubicin for Targeted Prostate Cancer Delivery
- (2017) Sylvie Skalickova et al. Nanomaterials
- Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance?
- (2016) Zbynek Heger et al. CURRENT DRUG TARGETS
- SOD1 Lysine 123 Acetylation in the Adult Central Nervous System
- (2016) Michael Kaliszewski et al. Frontiers in Cellular Neuroscience
- Application of C60 Fullerene-Doxorubicin Complex for Tumor Cell Treatment In Vitro and In Vivo
- (2015) R. R. Panchuk et al. Journal of Biomedical Nanotechnology
- Chronic Oxidative Stress Increases Growth and Tumorigenic Potential of MCF-7 Breast Cancer Cells
- (2014) Prathap Kumar S. Mahalingaiah et al. PLoS One
- The role of metallothionein interactions with other proteins
- (2014) Marta Zalewska et al. PROTEOMICS
- Cardioprotective Effects of Fullerenol C60(Oh)24 on a Single Dose Doxorubicin-induced Cardiotoxicity in Rats with Malignant Neoplasm
- (2014) Rade Injac et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- C60 Fullerene as Synergistic Agent in Tumor-Inhibitory Doxorubicin Treatment
- (2014) Svitlana Prylutska et al. Drugs in research & development
- Regulation of CuZnSOD and Its Redox Signaling Potential: Implications for Amyotrophic Lateral Sclerosis
- (2013) Michael J. Hitchler et al. ANTIOXIDANTS & REDOX SIGNALING
- The Free Radical Theory of Aging Is Dead. Long Live the Damage Theory!
- (2013) Vadim N. Gladyshev ANTIOXIDANTS & REDOX SIGNALING
- The Role of Metallothionein in Oxidative Stress
- (2013) Branislav Ruttkay-Nedecky et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting SOD1 reduces experimental non–small-cell lung cancer
- (2013) Andrea Glasauer et al. JOURNAL OF CLINICAL INVESTIGATION
- Possible Mechanisms of Fullerene C60Antioxidant Action
- (2013) V. A. Chistyakov et al. Biomed Research International
- Effect of fullerenol C60(OH)24 on lipid peroxidation of kidneys, testes and lungs in rats treated with doxorubicine
- (2012) Ivana Vapa et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Multi walled carbon nano tubes induced hepatotoxicity in Swiss albino mice
- (2012) Kumud Kant Awasthi et al. MICRON
- Applications of Functionalized Fullerenes in Tumor Theranostics
- (2012) Zhiyun Chen et al. Theranostics
- Fullerene C60 as a multifunctional system for drug and gene delivery
- (2011) Alejandro Montellano et al. Nanoscale
- Anthracyclines and ellipticines as DNA-damaging anticancer drugs: Recent advances
- (2011) Rene Kizek et al. PHARMACOLOGY & THERAPEUTICS
- Potent Angiogenesis Inhibition by the Particulate Form of Fullerene Derivatives
- (2010) Huan Meng et al. ACS Nano
- Silencing the Metallothionein-2A Gene Induces Entosis in Adherent MCF-7 Breast Cancer Cells
- (2010) Yiyang Lai et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Nanoscale enzyme inhibitors: Fullerenes inhibit carbonic anhydrase by occluding the active site entrance
- (2010) Alessio Innocenti et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Metallothionein-2A overexpression increases the expression of matrix metalloproteinase-9 and invasion of breast cancer cells
- (2010) Hyung Gyun Kim et al. FEBS LETTERS
- Reactive oxygen species in cancer
- (2010) Geou-Yarh Liou et al. FREE RADICAL RESEARCH
- Cu,Zn Superoxide Dismutase Maturation and Activity Are Regulated by COMMD1
- (2010) Willianne I. M. Vonk et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mitochondrial Dysfunction and Reactive Oxygen Species Imbalance Promote Breast Cancer Cell Motility through a CXCL14-Mediated Mechanism
- (2009) H. Pelicano et al. CANCER RESEARCH
- Nanoparticle-based targeted drug delivery
- (2009) Rajesh Singh et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Change of Zinc, Copper, and Metallothionein Concentrations and the Copper-Zinc Superoxide Dismutase Activity in Patients With Pancreatitis
- (2009) Halina Milnerowicz et al. PANCREAS
- Silencing the Metallothionein-2A gene inhibits cell cycle progression from G1- to S-phase involving ATM and cdc25A signaling in breast cancer cells
- (2008) Daina Lim et al. CANCER LETTERS
- Anti‐oxidant Properties of C60Fullerenesin vitro
- (2008) S. V. Prylutska et al. FULLERENES NANOTUBES AND CARBON NANOSTRUCTURES
- Effects of Cu/Zn Superoxide Dismutase on Estrogen Responsiveness and Oxidative Stress in Human Breast Cancer Cells
- (2008) Abhi K. Rao et al. MOLECULAR ENDOCRINOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started